Renal Osteodystrophy
1 medicine
Renal osteodystrophy is bone disease caused by chronic kidney disease, where disturbed calcium, phosphate and vitamin D metabolism weakens the bones. Active vitamin D is a mainstay of treatment.
Key facts
- Renal osteodystrophy is a bone disorder that develops as a direct result of chronic kidney disease (CKD), when calcium and phosphate fall out of balance and the body stops activating vitamin D.
- The result is weakened, brittle bone that fractures more easily and causes persistent aching, especially in the hips, knees and lower back.
- Treatment restores the missing active vitamin D; calcitriol is the synthetic form most often used to suppress parathyroid hormone and slow bone loss, as part of bone health in kidney disease.
- Untreated secondary hyperparathyroidism can progress quickly.
Why the kidneys matter for bone health
Healthy kidneys activate vitamin D, which the body needs to absorb calcium from food. In CKD this conversion breaks down. Low active vitamin D drives the parathyroid glands to overproduce parathyroid hormone (PTH), which then pulls calcium directly from bone to compensate. Over months and years this cycle erodes bone density and alters bone structure. Treatment focuses on replacing that missing active vitamin D: calcitriol suppresses PTH and slows bone loss, and managing it is a core part of bone health for people with kidney disease.
When to see a doctor
Persistent bone pain, muscle weakness, or unexplained fractures in someone with CKD warrant prompt review by a kidney specialist, since untreated secondary hyperparathyroidism can advance rapidly.
This page is educational and does not replace advice from a doctor or pharmacist who knows your health history.